| Product NDC: | 46084-031 |
| Proprietary Name: | APTIDINE |
| Non Proprietary Name: | RANITIDINE HYDROCHLORIDE |
| Active Ingredient(s): | 75 mg/1 & nbsp; RANITIDINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 46084-031 |
| Labeler Name: | A P J Laboratories Limited |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA075132 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130301 |
| Package NDC: | 46084-031-12 |
| Package Description: | 12 TABLET in 1 BLISTER PACK (46084-031-12) |
| NDC Code | 46084-031-12 |
| Proprietary Name | APTIDINE |
| Package Description | 12 TABLET in 1 BLISTER PACK (46084-031-12) |
| Product NDC | 46084-031 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | RANITIDINE HYDROCHLORIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130301 |
| Marketing Category Name | ANDA |
| Labeler Name | A P J Laboratories Limited |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |